Richard A Scolyer Selected Research

Richard A Scolyer Research Topics

Disease

278	Melanoma (Melanoma, Malignant) 05/2024 - 08/2002
158	Neoplasms (Cancer) 04/2024 - 08/2002
65	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2003
12	Nevus (Nevi) 04/2022 - 08/2002
10	Lymphatic Metastasis 04/2022 - 04/2004
8	Skin Neoplasms (Skin Cancer) 10/2023 - 02/2012
8	Brain Neoplasms (Brain Tumor) 01/2023 - 05/2015
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015 - 01/2004
7	Phyllodes Tumor (Cystosarcoma Phylloides) 12/2012 - 07/2002
6	Uveal melanoma 12/2023 - 02/2014
6	Disease Progression 12/2022 - 01/2010
5	Neoplasm Micrometastasis 12/2022 - 07/2004
5	Margins of Excision 01/2019 - 04/2006
4	Extranodal Extension 12/2022 - 04/2012
4	Tonsillar Neoplasms 11/2016 - 09/2003
4	Carcinogenesis 05/2015 - 02/2012
3	Squamous Cell Carcinoma of Head and Neck 10/2023 - 10/2016
3	Basal Cell Carcinoma (Rodent Ulcer) 03/2023 - 05/2013
3	Colitis 11/2022 - 01/2019
3	Lung Neoplasms (Lung Cancer) 03/2022 - 01/2022
3	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2009
3	Neuroblastoma 11/2017 - 02/2012
2	Actinic Keratosis 03/2023 - 10/2015
2	Inflammation (Inflammations) 01/2023 - 01/2017
2	Hypoxia (Hypoxemia) 01/2023 - 04/2014
2	Hypothyroidism 01/2022 - 01/2021
2	Thyrotoxicosis 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 01/2022 - 05/2004

Drug/Important Bio-Agent (IBA)

45	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2003
39	Immune Checkpoint InhibitorsIBA 04/2024 - 02/2015
34	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2002
26	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2002
22	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2022 - 03/2014
17	ParaffinIBA 01/2023 - 02/2004
14	IpilimumabIBA 10/2023 - 12/2015
13	LigandsIBA 10/2023 - 12/2004
13	AntigensIBA 01/2023 - 05/2004
13	Formaldehyde (Formol)FDA Link 01/2023 - 12/2004
11	pembrolizumabIBA 03/2024 - 12/2015
11	NivolumabIBA 02/2024 - 12/2015
10	dabrafenibIBA 05/2024 - 03/2012
10	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2020
10	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2011
10	Phosphotransferases (Kinase)IBA 11/2017 - 08/2006
8	trametinibIBA 05/2024 - 12/2014
8	Eosine Yellowish-(YS) (Eosin)IBA 04/2024 - 09/2003
8	AntibodiesIBA 01/2022 - 06/2010
8	VemurafenibIBA 12/2015 - 03/2012
7	Circulating Tumor DNAIBA 01/2022 - 12/2015
7	Messenger RNA (mRNA)IBA 12/2021 - 09/2003
6	Hematoxylin (Haematoxylon)IBA 04/2024 - 09/2003
6	Cyclin D1IBA 10/2009 - 09/2003
5	ChemokinesIBA 01/2023 - 02/2008
5	CytokinesIBA 01/2023 - 03/2014
5	EnzymesIBA 01/2019 - 09/2012
5	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2011 - 09/2003
5	Protons (Proton)IBA 08/2010 - 06/2003
4	Niacinamide (Nicotinamide)FDA LinkGeneric 03/2023 - 10/2015
4	5-hydroxymethylcytosineIBA 12/2022 - 09/2012
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2010
4	ChromatinIBA 01/2021 - 08/2002
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 03/2012
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 03/2014
4	Capsules (Microcapsules)IBA 04/2012 - 07/2004
4	Cell Cycle ProteinsIBA 10/2009 - 09/2003
4	AntimonyIBA 05/2008 - 03/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 10/2006
3	InterferonsIBA 01/2024 - 01/2019
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2022 - 07/2004
3	MART-1 AntigenIBA 12/2021 - 09/2015
3	SuspensionsIBA 01/2021 - 06/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 01/2013
3	CateninsIBA 12/2017 - 01/2014
3	Mitogen-Activated Protein KinasesIBA 11/2017 - 04/2014
3	B7-H1 AntigenIBA 11/2017 - 07/2016
3	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 12/2009
3	Glucose (Dextrose)FDA LinkGeneric 07/2015 - 03/2009
3	Cadherins (E-Cadherin)IBA 05/2013 - 04/2003
2	SteroidsIBA 05/2024 - 11/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 09/2004
2	Programmed Cell Death 1 ReceptorIBA 10/2023 - 11/2020
2	Antineoplastic Agents (Antineoplastics)IBA 10/2023 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 08/2023 - 04/2009
2	CarbonIBA 01/2023 - 05/2008
2	Differentiation AntigensIBA 01/2023 - 12/2020
2	NucleotidesIBA 01/2023 - 12/2015
2	GTP-Binding Proteins (G-Protein)IBA 12/2022 - 02/2012
2	Apoptosis Regulatory ProteinsIBA 01/2022 - 01/2010
2	Imiquimod (Aldara)FDA LinkGeneric 01/2022 - 11/2021

Therapy/Procedure

112	Therapeutics 05/2024 - 05/2004
73	Immunotherapy 04/2024 - 09/2012
31	Lymph Node Excision (Lymph Node Dissection) 05/2024 - 07/2004
11	Neoadjuvant Therapy 05/2024 - 01/2019
9	Radiotherapy 10/2023 - 06/2007
8	Drug Therapy (Chemotherapy) 08/2023 - 01/2017
6	Precision Medicine 07/2022 - 12/2012
5	Adjuvant Radiotherapy 11/2017 - 09/2008
4	Chemoprevention 03/2023 - 10/2015
4	Aftercare (After-Treatment) 05/2022 - 03/2012
3	Molecular Targeted Therapy 01/2020 - 01/2008